CN115335389A - 亲环蛋白抑制剂及其用途 - Google Patents

亲环蛋白抑制剂及其用途 Download PDF

Info

Publication number
CN115335389A
CN115335389A CN202180023394.0A CN202180023394A CN115335389A CN 115335389 A CN115335389 A CN 115335389A CN 202180023394 A CN202180023394 A CN 202180023394A CN 115335389 A CN115335389 A CN 115335389A
Authority
CN
China
Prior art keywords
compound
organ
alkyl
formula
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202180023394.0A
Other languages
English (en)
Chinese (zh)
Inventor
麦靖邦
H·弗莱里
马法书
M·皮尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ruinuo Medical Technology Shanghai Co ltd
Original Assignee
Ruinuo Medical Technology Shanghai Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ruinuo Medical Technology Shanghai Co ltd filed Critical Ruinuo Medical Technology Shanghai Co ltd
Publication of CN115335389A publication Critical patent/CN115335389A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/12—Chemical aspects of preservation
    • A01N1/122—Preservation or perfusion media
    • A01N1/126—Physiologically active agents, e.g. antioxidants or nutrients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C07K7/645—Cyclosporins; Related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Analytical Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CN202180023394.0A 2020-03-26 2021-03-25 亲环蛋白抑制剂及其用途 Pending CN115335389A (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CN2020081295 2020-03-26
CNPCT/CN2020/081295 2020-03-26
CNPCT/CN2021/078391 2021-03-01
CN2021078391 2021-03-01
PCT/CN2021/083013 WO2021190601A1 (en) 2020-03-26 2021-03-25 Cyclophilin inhibitors and uses thereof

Publications (1)

Publication Number Publication Date
CN115335389A true CN115335389A (zh) 2022-11-11

Family

ID=77891510

Family Applications (2)

Application Number Title Priority Date Filing Date
CN202180023394.0A Pending CN115335389A (zh) 2020-03-26 2021-03-25 亲环蛋白抑制剂及其用途
CN202180023172.9A Pending CN115298199A (zh) 2020-03-26 2021-03-25 环孢菌素衍生物的制备

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN202180023172.9A Pending CN115298199A (zh) 2020-03-26 2021-03-25 环孢菌素衍生物的制备

Country Status (11)

Country Link
US (3) US20230174583A1 (https=)
EP (2) EP4126905A4 (https=)
JP (2) JP7761578B2 (https=)
KR (2) KR20220158761A (https=)
CN (2) CN115335389A (https=)
AU (1) AU2021240762A1 (https=)
BR (1) BR112022018929A2 (https=)
CA (2) CA3172601A1 (https=)
IL (1) IL296586B1 (https=)
MX (1) MX2022011697A (https=)
WO (2) WO2021190601A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113329626A (zh) * 2019-01-20 2021-08-31 睿诺医疗科技（上海）有限公司 环孢菌素类似物及其用途

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2020363688A1 (en) 2019-10-12 2022-04-21 Farsight Medical Technology (Shanghai) Co., Ltd. Treatment and prevention of nephrotoxin-induced kidney injuries
IL296586B1 (en) * 2020-03-26 2026-04-01 Farsight Medical Tech Shanghai Co Ltd Cyclophilin inhibitors and their uses
AU2021256222A1 (en) 2020-04-15 2022-10-06 Farsight Medical Technology (Shanghai) Co., Ltd. Prevention and treatment of organ injuries
GB202207348D0 (en) * 2022-05-19 2022-07-06 Cypralis Ltd Macrocyclic compounds and uses thereof
WO2024183651A1 (en) * 2023-03-03 2024-09-12 Farsight Medical Technology (Shanghai) Co., Ltd. Treatment and prevention of agent‐induced liver conditions or diseases
KR20260018851A (ko) * 2023-06-02 2026-02-09 파사이트 메디컬 테크놀로지 (상하이) 컴퍼니 리미티드 사이클로필린 저해제 및 그 용도

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0194972B1 (en) 1985-03-11 1992-07-29 Sandoz Ag Novel cyclosporins
FI111730B (fi) 1990-11-02 2003-09-15 Novartis Ag Menetelmä ei-immunosuppressiivisen syklosporiinin valmistamiseksi
AU750245B2 (en) * 1997-10-08 2002-07-11 Aurinia Phamaceuticals Inc. Deuterated cyclosporine analogs and their use as immunomodulating agents
CN1205220C (zh) 1998-06-12 2005-06-08 斯－凯穆公司 新颖的环孢菌素
US6809077B2 (en) 2001-10-12 2004-10-26 Enanta Pharmaceuticals, Inc. Cyclosporin analogs for the treatment of autoimmune diseases
CN100344648C (zh) 2001-10-19 2007-10-24 伊索泰克尼卡股份有限公司 环孢菌素类似物混合物及其在制备免疫调节剂中的用途
US7538084B2 (en) 2003-03-17 2009-05-26 Amr Technology, Inc. Cyclosporins
SI1802650T1 (sl) 2004-10-01 2012-03-30 Scynexis Inc Eter in tioeter substituirani ciklosporinski derivati za zdravljenje in preventivo pred infekcijami s hepatitisom c
ZA200703157B (en) * 2004-10-01 2008-08-27 Scynexis Inc 3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis C infection
EP2023918B1 (en) * 2006-05-19 2011-03-23 Scynexis, Inc. Cyclosporins for the treatment and prevention of ocular disorders
WO2008143996A1 (en) * 2007-05-18 2008-11-27 Scynexis, Inc. New chemical processes
AU2009276241A1 (en) 2008-07-30 2010-02-04 Ciclofilin Pharmaceuticals Corp. Nonimmunosuppressive cyclosporine analogue molecules
KR20110111321A (ko) * 2009-01-30 2011-10-10 이난타 파마슈티칼스, 인코포레이티드 Ｃ형 간염을 예방하거나 치료하기 위한 사이클로스포린 유사체
US8481483B2 (en) 2009-02-19 2013-07-09 Enanta Pharmaceuticals, Inc. Cyclosporin analogues
WO2011082289A1 (en) * 2009-12-30 2011-07-07 Scynexis Inc. Cyclosporine analogues
WO2012009715A2 (en) * 2010-07-16 2012-01-19 S&T Global Inc. Novel cyclosporin derivatives for the treatment and prevention of a viral infection
US9890198B2 (en) * 2010-12-03 2018-02-13 S&T Global Inc. Cyclosporin derivatives and uses thereof
BR112013014890B1 (pt) 2010-12-15 2023-10-24 Contravir Pharmaceuticals, Inc Composto análogo de moléculas pertencentes à família ciclosporina, composição farmacêutica compreendendo o mesmo, uso terapêutico ou profilático do referido composto e processos para a preparação dos mesmos
DE102011111991A1 (de) * 2011-08-30 2013-02-28 Lead Discovery Center Gmbh Neue Cyclosporin-Derivate
GB201217560D0 (en) 2012-10-02 2012-11-14 Mitopharm Ltd Novel cyclic depsipeptide compounds and their uses
US20140212381A1 (en) * 2012-10-19 2014-07-31 Scynexis, Inc. Macrocycles
GB201222455D0 (en) * 2012-12-13 2013-01-30 Perioc Ltd Novel pharmaceutical formulations and their use in the treatment of periodontaldisease
GB201414806D0 (en) 2014-08-20 2014-10-01 Ucl Business Plc Cyclosporin conjugates
WO2017004304A1 (en) * 2015-06-30 2017-01-05 Cypralis Limited Novel macrocycles
CN106902346A (zh) * 2015-12-23 2017-06-30 中美华世通生物医药科技（武汉）有限公司 药物组合物及其制药用途
CN106902347A (zh) * 2015-12-23 2017-06-30 中美华世通生物医药科技（武汉）有限公司 亲环孢素抑制剂的用途
CN118324867A (zh) * 2016-05-17 2024-07-12 美国科技环球有限公司 新型环孢菌素衍生物及其用途
GB201711749D0 (en) * 2017-07-21 2017-09-06 Cypralis Ltd Cyclosporin analogues and uses thereof
WO2020037530A1 (en) * 2018-08-22 2020-02-27 Waterstone Pharmaceuticals (Wuhan) Co., Ltd. Crystalline form of compound and uses thereof in medicine
CN111449050A (zh) * 2019-01-20 2020-07-28 睿诺医疗科技（上海）有限公司 环孢菌素类似物及其用途
IL296586B1 (en) * 2020-03-26 2026-04-01 Farsight Medical Tech Shanghai Co Ltd Cyclophilin inhibitors and their uses

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113329626A (zh) * 2019-01-20 2021-08-31 睿诺医疗科技（上海）有限公司 环孢菌素类似物及其用途

Also Published As

Publication number Publication date
EP4126905A1 (en) 2023-02-08
JP2023518777A (ja) 2023-05-08
MX2022011697A (es) 2022-10-07
TW202144379A (zh) 2021-12-01
US20230174583A1 (en) 2023-06-08
JP7776435B2 (ja) 2025-11-26
US20240352074A1 (en) 2024-10-24
EP4126904A4 (en) 2024-05-29
IL296586A (en) 2022-11-01
IL296586B1 (en) 2026-04-01
JP7761578B2 (ja) 2025-10-28
CN115298199A (zh) 2022-11-04
US20230110497A1 (en) 2023-04-13
US12522634B2 (en) 2026-01-13
KR20220158760A (ko) 2022-12-01
BR112022018929A2 (pt) 2022-12-06
JP2023518776A (ja) 2023-05-08
AU2021240762A1 (en) 2022-10-06
CA3172601A1 (en) 2021-09-30
WO2021190601A1 (en) 2021-09-30
EP4126904A1 (en) 2023-02-08
CA3172535A1 (en) 2021-09-30
WO2021190604A1 (en) 2021-09-30
US12060440B2 (en) 2024-08-13
KR20220158761A (ko) 2022-12-01
EP4126905A4 (en) 2024-05-29

Similar Documents

Publication Publication Date Title
JP7776435B2 (ja) シクロフィリン阻害剤およびその使用
CN115315432A (zh) 亲环蛋白抑制剂及其用途
JP2016512821A (ja) ヘモグロビンの修飾のための組成物及び方法
EP2318015B1 (en) Treatment of cancers of the blood using selected glycomimetic compounds
WO2009052116A1 (en) Methods for treating a variety of diseases and conditions, and compounds useful therefor
US20200171122A1 (en) Cyclosporin analogues and uses thereof
JP7839090B2 (ja) ネフロトキシン誘発性腎障害の処置及び予防
TWI917366B (zh) 親環蛋白抑制劑及其用途
EP1711462A1 (de) Prolinderivate als pharmazeutische wirkstoffe in der tumortherapie
EA051978B1 (ru) Ингибиторы циклофилина и их применение
US12318368B2 (en) Physics-driven discovery of novel small therapeutic compounds for use as a BCL-2 inhibitor
US7732485B2 (en) Treatment of cancer
KR101213600B1 (ko) 데커신 및/또는 데커시놀 안젤레이트, 또는 데커신및/또는 데커시놀 안젤레이트를 유효성분으로 하는당귀추출물을 포함하는 신기능 치료제 조성물
US12435074B2 (en) Physics-driven discovery of novel small therapeutic compounds for use as a BCL-2 inhibitor
US12297175B2 (en) Physics-driven discovery of novel small therapeutic compounds for use as a BCL-2 inhibitor
US12384746B2 (en) Physics-driven discovery of novel small therapeutic compounds for use as a BCL-2 inhibitor
US12398128B2 (en) Physics-driven discovery of novel small therapeutic compounds for use as a BCL-2 inhibitor
KR20050039700A (ko) 이식거부 치료용 화합물 및 치료 방법
CN120936356A (zh) 以7-脱氢胆固醇或其盐、氧化物、代谢物或衍生物用于预防或治疗肺动脉高压的方法
KR0156985B1 (ko) 신규 2-클로로-3-치환아미노-1,4-나프탈렌디온 유도체
US20040152772A1 (en) 1-butyric acid derivatives and the use thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination